CybeRelease: (OTC: TKAT) Announces Positive Phase II Trials
(CybeRelease, January 3, 2007) - Lake Harmony, PA - Teeka Tan Products Inc. (OTCBB:TKAT - News), announced today that it has completed the second phase of testing on a patent pending sunscreen formulation containing a proven chemical shark repellent (SharkDefense, LLC.). Working in conjunction with SharkDefense, a scientific study was conducted at the Bimini Biological Field Station, South Bimini, Bahamas. The study, comprised of a series of nine Phase 2 trials, indicated that lemon sharks, which were conditioned to feed on mammalian flesh baits (i.e. pig ears), avoided baits that were treated with a SharkDefense repellent/Teeka Tan Sport SPF 30 formula. The sharks preferred untreated baits in controlled experiments where a choice of baits was offered.
“These trials represent the most stringent conditions which will rarely be encountered in the natural environment because these sharks were trained to feed and expecting the bait to be edible. Under natural conditions, sharks foraging for food will typically be more cautious and therefore more likely to be repelled,” stated Patrick Rice, coordinating Marine Biologist from the University of Miami.
Phase 3 of this research will focus on repeating the final positive results of Phase 2 trials to obtain enough replicates for statistical confidence as well as improving the cosmetics of this combined formulation. This innovation is the only known shark repellent suncare product and the company hopes to finish Phase III trials and launch the new sunscreen/shark repellent formulations in the 2007 suncare season.
To read the complete release, go to http://biz.yahoo.com/bw/070103/20070103005742.html?.v=1
For a Free News letter, go to http://www.OTCReporter.com
CybeRelease Gainers are Sirius Satellite Radio Inc. (Nasdaq: SIRI), Tellabs, Inc. (Nasdaq: TLAB), EGL, Inc. (Nasdaq: EAGL), MIVA, Inc. (Nasdaq: MIVA), J.B. Hunt Transport Services, Inc. (Nasdaq: JBHT), UAL Corporation (Nasdaq: UAUA), Pacific Sunwear of California, Inc. (Nasdaq: PSUN) and Cytokinetics, Incorporated (Nasdaq: CYTK).
CybeRelease Decliners are Delta Petroleum Corporation (Nasdaq: DPTR), Parallel Petroleum Corporation (Nasdaq: PLLL), Bucyrus International, Inc. (Nasdaq: BUCY), Novavax, Inc. (Nasdaq: NVAX), Sigma-Aldrich Corporation (Nasdaq: SIAL), James River Coal Company (Nasdaq: JRCC), Carrizo Oil & Gas, Inc. (Nasdaq: CRZO) and Particle Drilling Technologies, Inc. (Nasdaq: PDRT).
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for informational purposes only and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $500.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.
- Contact Information
- C. P. Barry
- Media Contact
- Contact via E-mail
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.